Cargando…

P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS

Detalles Bibliográficos
Autores principales: Hu, Shiwei, Wu, Dijiong, Feng, Weiying, Chen, Lili, Cao, Lihong, Zhu, Xiaoqiong, Yang, Xiudi, Zhu, Jingjing, Wang, Huafeng, Chen, Dan, Tong, Hongyan, Lu, Ying, Qian, Honglan, Wang, Yi, Jin, Jie, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428900/
http://dx.doi.org/10.1097/01.HS9.0000969560.77193.a9
_version_ 1785090581507080192
author Hu, Shiwei
Wu, Dijiong
Feng, Weiying
Chen, Lili
Cao, Lihong
Zhu, Xiaoqiong
Yang, Xiudi
Zhu, Jingjing
Wang, Huafeng
Chen, Dan
Tong, Hongyan
Lu, Ying
Qian, Honglan
Wang, Yi
Jin, Jie
Huang, Jian
author_facet Hu, Shiwei
Wu, Dijiong
Feng, Weiying
Chen, Lili
Cao, Lihong
Zhu, Xiaoqiong
Yang, Xiudi
Zhu, Jingjing
Wang, Huafeng
Chen, Dan
Tong, Hongyan
Lu, Ying
Qian, Honglan
Wang, Yi
Jin, Jie
Huang, Jian
author_sort Hu, Shiwei
collection PubMed
description
format Online
Article
Text
id pubmed-10428900
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104289002023-08-17 P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS Hu, Shiwei Wu, Dijiong Feng, Weiying Chen, Lili Cao, Lihong Zhu, Xiaoqiong Yang, Xiudi Zhu, Jingjing Wang, Huafeng Chen, Dan Tong, Hongyan Lu, Ying Qian, Honglan Wang, Yi Jin, Jie Huang, Jian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428900/ http://dx.doi.org/10.1097/01.HS9.0000969560.77193.a9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Hu, Shiwei
Wu, Dijiong
Feng, Weiying
Chen, Lili
Cao, Lihong
Zhu, Xiaoqiong
Yang, Xiudi
Zhu, Jingjing
Wang, Huafeng
Chen, Dan
Tong, Hongyan
Lu, Ying
Qian, Honglan
Wang, Yi
Jin, Jie
Huang, Jian
P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
title P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
title_full P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
title_fullStr P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
title_full_unstemmed P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
title_short P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
title_sort p664: real-world analysis of mutation characteristics and clinical outcomes in 343 chronic myeloid leukemia patients with bcr::abl kinase domain mutations
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428900/
http://dx.doi.org/10.1097/01.HS9.0000969560.77193.a9
work_keys_str_mv AT hushiwei p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT wudijiong p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT fengweiying p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT chenlili p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT caolihong p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT zhuxiaoqiong p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT yangxiudi p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT zhujingjing p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT wanghuafeng p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT chendan p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT tonghongyan p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT luying p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT qianhonglan p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT wangyi p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT jinjie p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations
AT huangjian p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations